• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌相关微生物与代谢产物的研究进展

Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites.

作者信息

Han Shuwen, Zhuang Jing, Wu Yinhang, Wu Wei, Yang Xi

机构信息

Department of Oncology, Huzhou Cent Hospital, Affiliated Cent Hospital HuZhou University, Huzhou 313000, People's Republic of China.

Graduate School of Nursing, Huzhou University, Huzhou 313000, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Sep 21;12:8703-8720. doi: 10.2147/CMAR.S268943. eCollection 2020.

DOI:10.2147/CMAR.S268943
PMID:33061569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7518784/
Abstract

Intestinal flora is an important component in the human body, which have been reported to be involved in the occurrence and development of colorectal cancer (CRC). Indeed, changes in the intestinal flora in CRC patients compared to those in control subjects have been reported. Several bacterial species have been shown to exhibit the pro-inflammatory and pro-carcinogenic properties, which could consequently have an impact on colorectal carcinogenesis. In this review, we summarize the current knowledge on the potential links between the intestinal microbiota and CRC. We illustrated the mechanisms by which intestinal flora imbalance affects CRC, mainly focusing on inflammation, microbial metabolites, and specific bacteria species. In addition, we discuss how a diet exhibits a strong impact on microbial composition and provides risks for developing CRC. Finally, we describe the potential future directions that are based on intestinal microbiota manipulation for CRC diagnosis and treatment.

摘要

肠道菌群是人体的重要组成部分,据报道其与结直肠癌(CRC)的发生和发展有关。事实上,已有报道称CRC患者的肠道菌群与对照受试者相比存在变化。几种细菌已被证明具有促炎和促癌特性,这可能会对结直肠癌的发生产生影响。在本综述中,我们总结了目前关于肠道微生物群与CRC之间潜在联系的知识。我们阐述了肠道菌群失衡影响CRC的机制,主要集中在炎症、微生物代谢产物和特定细菌种类上。此外,我们讨论了饮食如何对微生物组成产生强烈影响并增加患CRC的风险。最后,我们描述了基于肠道微生物群调控用于CRC诊断和治疗的潜在未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/282532f1bada/CMAR-12-8703-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/8a0b2398be26/CMAR-12-8703-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/64b971447f1c/CMAR-12-8703-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/2974b515099b/CMAR-12-8703-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/9737a15e2183/CMAR-12-8703-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/eafac8257e8d/CMAR-12-8703-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/282532f1bada/CMAR-12-8703-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/8a0b2398be26/CMAR-12-8703-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/64b971447f1c/CMAR-12-8703-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/2974b515099b/CMAR-12-8703-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/9737a15e2183/CMAR-12-8703-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/eafac8257e8d/CMAR-12-8703-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c67a/7518784/282532f1bada/CMAR-12-8703-g0006.jpg

相似文献

1
Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites.结直肠癌相关微生物与代谢产物的研究进展
Cancer Manag Res. 2020 Sep 21;12:8703-8720. doi: 10.2147/CMAR.S268943. eCollection 2020.
2
Microbiota, Inflammation and Colorectal Cancer.微生物群、炎症与结直肠癌
Int J Mol Sci. 2017 Jun 20;18(6):1310. doi: 10.3390/ijms18061310.
3
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
4
Colorectal cancer occurrence and treatment based on changes in intestinal flora.基于肠道菌群变化的结直肠癌发生和治疗。
Semin Cancer Biol. 2021 May;70:3-10. doi: 10.1016/j.semcancer.2020.05.004. Epub 2020 May 11.
5
Intestinal microbiota, chronic inflammation, and colorectal cancer.肠道微生物群、慢性炎症与结直肠癌
Intest Res. 2018 Jul;16(3):338-345. doi: 10.5217/ir.2018.16.3.338. Epub 2018 Jul 27.
6
[Role of gut microbiota in carcinogenesis and treatment for colorectal cancer].[肠道微生物群在结直肠癌发生及治疗中的作用]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):516-520. doi: 10.3760/cma.j.cn.441530-20190820-00314.
7
Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota.决定结直肠癌的因素:肠道微生物群的作用。
Front Oncol. 2015 Oct 12;5:220. doi: 10.3389/fonc.2015.00220. eCollection 2015.
8
Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges.结直肠癌中肠道微生物群衍生的代谢产物:有害之处与挑战
Front Oncol. 2021 Oct 18;11:739648. doi: 10.3389/fonc.2021.739648. eCollection 2021.
9
Molecular mechanistic pathway of colorectal carcinogenesis associated with intestinal microbiota.与肠道微生物群相关的结直肠癌发生的分子机制途径。
Anaerobe. 2018 Feb;49:63-70. doi: 10.1016/j.anaerobe.2017.12.008. Epub 2017 Dec 19.
10
Current Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer Prevention.关于膳食米糠摄入、肠道微生物群与预防结直肠癌之间关系的当前假说。
Nutrients. 2016 Sep 15;8(9):569. doi: 10.3390/nu8090569.

引用本文的文献

1
Characteristics of tongue images and tongue coating bacteria in patients with colorectal cancer.结直肠癌患者舌象及舌苔细菌的特征
BMC Microbiol. 2025 May 11;25(1):285. doi: 10.1186/s12866-025-04014-3.
2
Helminth-induced immune modulation in colorectal cancer: exploring therapeutic applications.蠕虫诱导的结直肠癌免疫调节:探索治疗应用
Front Immunol. 2025 Apr 14;16:1484686. doi: 10.3389/fimmu.2025.1484686. eCollection 2025.
3
The oncobiome; what, so what, now what?肿瘤微生物组;是什么、为何重要、又该如何应对?

本文引用的文献

1
Interaction of Cyclooxygenase-2 with Induces Gastric Chronic Nonresolving Inflammation and the Formation of Syndrome of Internal Block of Static Blood in -Related Gastric Diseases.环氧化酶-2与……的相互作用诱导胃慢性不愈性炎症及在……相关胃病中形成血瘀内阻证
Evid Based Complement Alternat Med. 2020 Apr 6;2020:7340814. doi: 10.1155/2020/7340814. eCollection 2020.
2
Intestinal microbiota and its association with colon cancer and red/processed meat consumption.肠道微生物群及其与结肠癌和红/加工肉类消费的关系。
J Gastroenterol Hepatol. 2021 Jan;36(1):75-88. doi: 10.1111/jgh.15042. Epub 2020 Apr 3.
3
Adequate Lymph Node Assessments and Investigation of Gut Microorganisms and Microbial Metabolites in Colorectal Cancer.
Microbiome Res Rep. 2025 Feb 27;4(1):16. doi: 10.20517/mrr.2024.89. eCollection 2025.
4
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases.肠道菌群失调相关疾病的粪便微生物群移植研究进展
Adv Sci (Weinh). 2025 Apr;12(13):e2413197. doi: 10.1002/advs.202413197. Epub 2025 Feb 27.
5
Efficacy of intestinal microorganisms on immunotherapy of non-small cell lung cancer.肠道微生物对非小细胞肺癌免疫治疗的疗效
Heliyon. 2024 Apr 18;10(9):e29899. doi: 10.1016/j.heliyon.2024.e29899. eCollection 2024 May 15.
6
Anti-angiogenesis in colorectal cancer therapy.结直肠癌治疗中的抗血管生成作用。
Cancer Sci. 2024 Mar;115(3):734-751. doi: 10.1111/cas.16063. Epub 2024 Jan 17.
7
An exploration of the effect of Chinese herbal compound on the occurrence and development of large intestine cancer and intestinal flora.中药复方对大肠癌发生发展及肠道菌群影响的探究
Heliyon. 2023 Dec 10;10(1):e23533. doi: 10.1016/j.heliyon.2023.e23533. eCollection 2024 Jan 15.
8
Mechanisms by which the intestinal microbiota affects gastrointestinal tumours and therapeutic effects.肠道微生物群影响胃肠道肿瘤及治疗效果的机制。
Mol Biomed. 2023 Nov 30;4(1):45. doi: 10.1186/s43556-023-00157-9.
9
Assessment of bacterial and viral gut communities in healthy and tumoral colorectal tissue using RNA and DNA deep sequencing.使用 RNA 和 DNA 深度测序评估健康和肿瘤性结直肠组织中的细菌和病毒肠道群落。
Cancer Med. 2023 Sep;12(18):19291-19300. doi: 10.1002/cam4.6483. Epub 2023 Aug 28.
10
Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer.肺癌患者的肠道微生物群落结构和粪便代谢产物特征。
Front Cell Infect Microbiol. 2023 Jul 27;13:1170326. doi: 10.3389/fcimb.2023.1170326. eCollection 2023.
结直肠癌中充分的淋巴结评估以及肠道微生物和微生物代谢产物的研究
Onco Targets Ther. 2020 Mar 4;13:1893-1906. doi: 10.2147/OTT.S242017. eCollection 2020.
4
Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men.粪便中硫代谢细菌群落与男性远端结直肠癌风险的关联。
Gastroenterology. 2020 Apr;158(5):1313-1325. doi: 10.1053/j.gastro.2019.12.029. Epub 2020 Jan 20.
5
Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.分析结直肠癌不同部位的预后、基因组、微生物组和微生物代谢组。
J Transl Med. 2019 Oct 29;17(1):353. doi: 10.1186/s12967-019-2102-1.
6
Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer.与 CapeOX 方案辅助化疗引起的化疗性腹泻相关的肠道微生物群在 III 期结肠癌切除术后的应用。
Gut Pathog. 2019 Apr 30;11:18. doi: 10.1186/s13099-019-0299-4. eCollection 2019.
7
Relationship between intestinal microorganisms and T lymphocytes in colorectal cancer.结直肠癌中肠道微生物与 T 淋巴细胞的关系。
Future Oncol. 2019 May;15(14):1655-1666. doi: 10.2217/fon-2018-0595. Epub 2019 May 2.
8
Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis.参与结直肠癌伴血脂异常的肠道微生物。
Cancer Biol Ther. 2019;20(1):81-89. doi: 10.1080/15384047.2018.1507255. Epub 2018 Sep 21.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
γδ T Cells: Crosstalk Between Microbiota, Chronic Inflammation, and Colorectal Cancer.γδ T细胞:微生物群、慢性炎症与结直肠癌之间的相互作用
Front Immunol. 2018 Jun 26;9:1483. doi: 10.3389/fimmu.2018.01483. eCollection 2018.